Associated tags: Charterhouse Capital Partners, Research, Environment, MIR, NYSE, Science, Health, Energy, Nuclear, Radiology
Locations: ILLINOIS, GEORGIA, UNITED STATES, NORTH AMERICA, CHICAGO, IL, CA
Retrieved on:
Thursday, February 22, 2024
Research,
Other Health,
General Health,
Other Defense,
Radiology,
Nuclear,
Energy,
Defense,
Health Technology,
Science,
Military,
Health,
Other Science,
SHARE,
Webcast,
MIR Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe.
Key Points:
- Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will participate in a SHARE Series fireside chat moderated by Wolfe Research Analyst, Nigel Coe.
- The event will begin at 9:00 AM ET on Monday, February 26, 2024 and will feature an online portal for investors to submit questions to ask during the event.
- The presentation will be webcast live at https://www.openexchange.tv/monday-management-update-february-26th/mirio... or may be accessed via our IR website at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section.
- An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event.
Retrieved on:
Thursday, February 22, 2024
Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.
Key Points:
Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY. The presentation will begin at 11:30 AM ET on Friday, March 1, 2024.
Retrieved on:
Tuesday, February 13, 2024
Manufacturing,
Science,
Other Science,
Research,
Chemicals,
Plastics,
Class,
Acquisition,
EPS,
Webcast,
MIR,
Internet service provider We delivered record revenue and adjusted EBITDA, and substantially improved cash generation and leverage,” stated Thomas Logan, Mirion’s Chief Executive Officer.
Key Points:
- We delivered record revenue and adjusted EBITDA, and substantially improved cash generation and leverage,” stated Thomas Logan, Mirion’s Chief Executive Officer.
- “Looking at our fourth quarter results, both business segments generated organic growth against tough comparisons from the same period last year.
- Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call.
- An archived replay of the call and an accompanying webcast will also be available on the Investors section of the Mirion website at https://ir.mirion.com/ .
Retrieved on:
Monday, February 12, 2024
Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL.
Key Points:
- Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL.
- The presentation will begin at 1:50 PM ET on Wednesday, February 21, 2024.
- The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section.
- An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event.
Retrieved on:
Wednesday, January 31, 2024
Mirion (NYSE: MIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024.
Key Points:
- Mirion (NYSE: MIR) announced today that it will release financial results for the fourth quarter and full year 2023 after market close on Tuesday, February 13, 2024.
- Following the news release, the company will host a conference call the next day, Wednesday, February 14, 2024, at 10:00 am ET to discuss the results.
- Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call.
- An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/ .
Retrieved on:
Thursday, November 16, 2023
Research,
General Health,
Other Energy,
Nuclear,
Sustainability,
Alternative Energy,
Energy,
Environment,
Science,
Green Technology,
Climate Change,
Health,
Other Science,
TerraPower,
NYSE,
Climate change,
Radiation,
Senior,
MCFR,
MIR,
Partnership,
Idaho National Laboratory,
Growth,
Uranium mining,
Southern Company Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world’s first critical fast-spectrum salt reactor.
Key Points:
- Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced an agreement with nuclear innovation company TerraPower to design and fabricate key components of their Molten Chloride Reactor Experiment (MCRE), the world’s first critical fast-spectrum salt reactor.
- This collaboration reinforces TerraPower and Mirion’s commitment to fostering sustainable, low-carbon energy solutions that address climate change and support a net-zero future.
- The MCRE will inform the design, licensing and operation of TerraPower’s Molten Chloride Fast Reactor (MCFR) – an innovative reactor technology that could provide low-cost, clean energy at scale.
- “Throughout the process of bringing the Molten Chloride Fast Reactor to market, we have found that working with a diverse supply chain strengthens our ability to deliver a cutting-edge technology,” said Jeff Latkowski, Senior Vice President for the Molten Chloride Fast Reactor.
Retrieved on:
Wednesday, November 1, 2023
Research,
Philanthropy,
Training,
Radiology,
Health,
Other Philanthropy,
Other Science,
Science,
Education,
DMC,
NYSE,
Therapy,
MD,
MIR,
ATS,
Partnership,
Hospital,
Radiation,
CT,
Developing country,
Nuclear medicine,
Medical imaging,
Medical device Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a philanthropic partnership with RAD-AID International to help bring radiology and radiation safety education and capabilities to underserved populations around the world.
Key Points:
- Mirion (NYSE: MIR), a leading provider of advanced radiation safety solutions, today announced a philanthropic partnership with RAD-AID International to help bring radiology and radiation safety education and capabilities to underserved populations around the world.
- As part of the partnership launch, Mirion made an in-kind donation to RAD-AID’s Medical Physics Program supporting healthcare efforts in Guyana, Grenada, Botswana, Morocco, Nigeria and Kenya.
- By aligning with RAD-AID, Mirion aims to extend its impact beyond technological advancements and actively contribute to improving quality healthcare access and outcomes for vulnerable populations.
- We look forward to leveraging our collective strengths across Mirion Technologies and Mirion Medical to support RAD-AID’s mission by empowering healthcare providers with the tools they need to save lives and improve patient outcomes.”
Retrieved on:
Wednesday, November 1, 2023
Chemicals,
Plastics,
Manufacturing,
Other Science,
Other Manufacturing,
Research,
Science,
Nuclear medicine,
NYSE,
Medicine,
EBITDA,
SIS,
Acquisition,
MIR,
EPS,
EC2,
Class,
Risk management,
Internet service provider On November 1, 2023, Mirion also closed the acquisition of ec2, with a purchase price of $33 million through an all cash purchase.
Key Points:
- On November 1, 2023, Mirion also closed the acquisition of ec2, with a purchase price of $33 million through an all cash purchase.
- “This was an excellent quarter for Mirion,” stated Thomas Logan, Mirion’s Chief Executive Officer.
- ec2 is estimated to generate a total of approximately $12 million in revenue and $5.5 million of proforma adjusted EBITDA for full year 2023, inclusive of pre-acquisition financial results.
- The guidance for organic revenue growth excludes the impact of foreign exchange rates as well as mergers, acquisitions and divestitures.
Retrieved on:
Tuesday, October 31, 2023
Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the Baird Global Industrial Conference in Chicago, IL.
Key Points:
- Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the Baird Global Industrial Conference in Chicago, IL.
- The presentation will begin at 10:40 AM ET on Tuesday, November 7, 2023.
- The presentation will be webcast live at https://ir.mirion.com/news-events where a link will be displayed under the "Events and Presentations” section.
- An archive of the webcast will be available at the same location within twelve hours of the conclusion of the event.
Retrieved on:
Wednesday, October 18, 2023
Mirion’s Chief Executive Officer, Thomas Logan, will reassume the responsibilities of Medical Group President until a permanent successor is named.
Key Points:
- Mirion’s Chief Executive Officer, Thomas Logan, will reassume the responsibilities of Medical Group President until a permanent successor is named.
- Mr. Logan had previously served as acting Medical Group President through much of 2022.
- “Mike has been a valued member of the Mirion executive team for the last year, and we are grateful for his contributions,” said Mr. Logan.
- “All of us at Mirion wish Mike well as he takes this next step in his career as a public company CEO.”
